High-dose-rate brachytherapy – a novel treatment approach for primary clear cell adenocarcinoma of male urethra

The incidence of male urethral cancer is rare with age preponderance of 50 to 60 years. The standard management approach is surgery. Here, we present a novel treatment approach for male urethral cancer. Thirty-six year old male, case of primary clear cell adenocarcinoma of urethra who refused surger...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Contemp Brachytherapy
Hlavní autoři: Lewis, Shirley, Pal, Mahendra, Bakshi, Ganesh, Ghadi, Yogesh G., Menon, Santosh, Murthy, Vedang, Mahantshetty, Umesh
Médium: Artigo
Jazyk:Inglês
Vydáno: Termedia Publishing House 2015
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4499518/
https://ncbi.nlm.nih.gov/pubmed/26207115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/jcb.2015.52316
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky